The Carlyle Group Announces Fourth Quarter and Full Year 2016 Financial Results
Feb 08, 2017 11:30 am UTC| Business
WASHINGTON, Feb. 08, 2017 -- Global alternative asset manager The Carlyle Group L.P. (NASDAQ:CG) today reported its unaudited results for the fourth quarter and full year ended December31, 2016. Carlyle Co-CEO...
Feb 08, 2017 11:30 am UTC| Business
NESS ZIONA, Israel, Feb. 08, 2017 -- Kamada Ltd. (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications,announced today the appointment of Gwen A. Melincoff to the...
Feb 08, 2017 11:13 am UTC| Business
Dublin, Feb. 08, 2017 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering. The worldwide...
Grace Announces $250 Million Share Repurchase Program
Feb 08, 2017 11:04 am UTC| Business
COLUMBIA, Md., Feb. 08, 2017 -- W. R. Grace Co. (NYSE:GRA) announced that its Board of Directors has authorized a new share repurchase program of up to $250 million expected to be completed over the next 24 to 36...
Grace to Increase Dividend 24 Percent Effective in the First Quarter 2017
Feb 08, 2017 11:02 am UTC| Business
COLUMBIA, Md., Feb. 08, 2017 -- W. R. Grace Co. (NYSE:GRA) announced today that its Board of Directors has approved a 24 percent increase in the company's regular annual cash dividend rate from $0.68 to $0.84 per...
Radware Announces Fourth Quarter and Full Year 2016 Earnings
Feb 08, 2017 11:00 am UTC| Business
Fourth Quarter 2016 Financial Highlights Revenues of $51.7 MillionNon-GAAP EPS of $0.06; GAAP EPS of ($0.05)Cash flow from operations of $23.3 MillionCash used for stock repurchase of $10.3 Million Full Year 2016...
Feb 08, 2017 11:00 am UTC| Business
VANCOUVER, British Columbia and DOYLESTOWN, Pa., Feb. 08, 2017 -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus...